tuberculosis-2017-scientifictracks-abstracts

2 / 20

Page 10
Notes:
September 20-21, 2017 | Philadelphia, USA
Global summit on
TUBERCULOSIS AND LUNG DISEASE
alliedacademies
Int J Respir Med 2017 Volume 2 Issue 2
Early diagnosis and treatment initiation of tuberculosis (TB)
is critical for patient survival, and infection control. The
session will cover patient management, clinical epidemiology
of TB, current laboratory tests used for TB diagnosis, and the
barriers of implementing rapid testing in resource-limited areas
through clinical research trials experience. Co-infection with
HIV and the rise of multi-drug resistant TB (MDR-TB) are two
major issues for tuberculosis management. Consequently, rapid
diagnostic testing is essential to identify infected individuals
to initiate therapeutic regimens. While novel, rapid methods
may be available in developed countries, there are barriers
for implementation in resource-limited settings. Management
strategies between the United States and developing countries,
by highlighting experiences in laboratory-focused clinical trials
in developing countries, where low cost tests using urine are
being assessed, will be also discussed. This session will provide
an opportunity to learn more about current and leading-edge
technologies available for TB testing both here and abroad, and
patient management.
Speaker Biography
Joan-Miquel Balada is the Director of Immunology and Associate Director of the Clini-
cal Microbiology at the Ohio State University Wexner Medical Center and an Associate
Professor of Pathology at the Ohio State University. He also directs the Mycobacteriol-
ogy Laboratory. His major research and clinical interest focus on the implementation
of rapid laboratory tests for the diagnosis of infectious diseases and its resistance pat-
tern with special interest of low cost tests for use in areas of limited resources. He is
working on antimicrobial resistance and tuberculosis global health initiatives in Central
America, Ethiopia and India.
Dr Wang is an Associate Professor of Internal Medicine in the Division of Infectious
Diseases at Ohio state University. She is the Medical Director of the Ben Franklin Tu-
berculosis Control Program, which reports and investigates all tuberculosis cases for
Franklin County, Ohio. Currently, she is also the Ohio Department of Health State Med-
ical TB Consultant as well as Medical TB Consultant for the CDC Regional Training and
Medical Consultation Center. Dr Wang’s clinical interest is in tuberculosis and tropical
medicine. Her major research interest has been molecular epidemiology and diagnosis
of tuberculosis. She also has overseas experience with TB in China and Guatemala. She
is a member of the Infectious Diseases Society of America.
e:
Joan-Miquel Balada
Ohio State University, USA
Shu-Hua Wang
Ohio State University, USA
The role of the laboratorian and clinician in the diagnosis and management of
tuberculosis in the US and developing countries